Update Results of Anlotinib Combined with TQB2450 (PD-L1 Blockade) As First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma (ESCC): A Single-Arm, Multicenter, Open-Label Phase II Clinical Trial.
Journal of Clinical Oncology（2023）
关键词
Stereotactic Body Radiation Therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要